Anaphylaxis following a transvaginal ultrasound by unknown
Jakubovic et al.  
Allergy Asthma Clin Immunol  (2016) 12:3 
DOI 10.1186/s13223-015-0106-9
CASE REPORT
Anaphylaxis following a transvaginal 
ultrasound
Baruch D. Jakubovic1*, Corey Saperia2 and Gordon L. Sussman1,2
Abstract 
Polyethylene glycol is a ubiquitous, water-soluble, organic compound found in a wide variety of commercially avail-
able products. While generally a benign substance, in rare instances, it can induce hypersensitivity reactions. Herein, 
we describe a case of anaphylaxis to polyethylene glycol-containing lubricating gel used for a transvaginal ultrasound. 
This case highlights the importance of early recognition of a rare cause of anaphylaxis that may occur in the health-
care setting. It is of particular importance given the widespread use of similar lubricating materials in multiple practice 
settings for the use of internal examinations and ultrasonography.
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Background
Polyethylene glycol (PEG) is a water-soluble, organic 
compound included in a wide variety of food products, 
cosmetics, and industrial materials [1, 2]. In the health-
care setting, it is also a common ingredient in medica-
tions and procedural agents. Specific case reports have 
documented PEG-associated hypersensitivity or ana-
phylaxis following ingestion of medication tablets [1, 2] 
as well as following whole-bowel irrigation for colonos-
copy or barium enema [3–6]. Reactions have also been 
described after administration of depot steroids [7, 8]. 
Lower doses of PEG therapy used for constipation man-
agement have been reported to cause anaphylaxis as well 
[9].
Anaphylactic reactions following transvaginal ultra-
sound procedures have also been described, but these 
were attributable to mucosal latex exposure from the 
condom-cover used for the ultrasound probe [10, 11]. 
Periprocedural reactions to gel-type products contain-
ing methyl celluloses and chlorhexidine have also been 
described [12, 13]. One brief report by Villa and col-
leagues from Italy, in a letter to the editor over 15 years 
ago attributed an anaphylactic reaction following a trans-
vaginal ultrasound to the gel, given the patient’s negative 
prick test to latex [14]. The authors speculated that the 
most plausible explanation was gel hypersensitivity, but 
did not elaborate further. Herein, we describe an anaphy-
lactic reaction post-transvaginal ultrasound attributable 
to the PEG contained within the lubricating gel.
Case
Within minutes of undergoing a transvaginal ultrasound, 
a 41  year old female developed immediate intra and 
perivaginal pruritus and burning. These symptoms did not 
resolve with self-administered cetirizine. Over the course 
of several hours, the patient developed a progressive mul-
tisystem reaction including cutaneous flushing, dyspnea, 
cough, nasal congestion, and generalized urticaria. Severe 
local labial swelling and throat tightness prompted her 
to seek emergent care at a nearby hospital. At her initial 
triage assessment, vital signs were within normal limits, 
though diffuse urticaria without angioedema was noted. 
Management included intramuscular epinephrine fol-
lowed by intravenous diphenhydramine, ranitidine, and 
corticosteroids for presumed anaphylaxis. Her symptoms 
subsequently abated and did not recur during or after 
her period of observation while at hospital. She was dis-
charged home with a prescription for prednisone 40 mg 
daily for 4  days along with an epinephrine autoinjector, 
and was referred for further allergic evaluation.
Her past medical history was significant for cold 
urticaria and an ovarian cyst for which she had a prior 
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resection and had been undergoing annual transvagi-
nal screening examinations for the previous 18  years. 
She had a similar reaction 1 year prior that started with 
local vaginal pruritus which was later followed by peri-
orbital and lingual swelling, urticaria, cough, and dysp-
nea. At that time, she had similarly presented to a local 
emergency department for acute management. She was a 
highly-active non-smoker, denied illicit drug use, and did 
not regularly consume alcohol. There was no personal or 
family history of atopy or autoimmunity. She was not tak-
ing any medications.
Allergy skin testing was performed by prick method 
to latex (low ammoniated natural rubber latex extract), 
as well as to samples provided by the patient from the 
non-latex condom that was used to cover the ultrasound 
probe and to the ultrasound gel used during the proce-
dure. Additional testing was performed to the individual 
gel components which were obtained from the gel man-
ufacturer (Chester Packaging, Cincinnati, OH). These 
included polyethylene glycol (molecular weight 8000), 
glycerin, carbomer, propylparaben, methylparaben, and 
sodium hydroxide. At 10  min, equally strongly positive 
reactions measuring 12 mm were noted to two gel sam-
ples (from separate gel sachets) as well as to the polyeth-
ylene glycol sample provided by the manufacturer. These 
results were validated in our patient by both positive his-
tamine and negative saline controls (Fig. 1). No specific 
increase in wheal size was noted in the subsequent period 
of time. Specific serum IgE (immunocap) testing to latex 
was also negative. Given a presumed IgE-mediated ana-
phylactic reaction to the polyethylene glycol, the patient 
was counselled regarding avoidance of PEG-containing 
substances by all routes in the future and advised to carry 
an epinephrine auto-injector with her at all times.
Discussion
This case highlights two key points of relevance: firstly, 
severe hypersensitivity reactions, though often imme-
diate in onset, can evolve over the course of minutes to 
hours. As the initial presenting symptoms may seem 
minor or benign in nature, clinical suspicion of an iatro-
genic reaction is warranted when new symptoms of any 
type develop immediately following a health care expo-
sure. Secondly, while rare, mucosal exposure to polyeth-
ylene glycol-containing products can trigger multisystem 
anaphylactic reactions.
Typically, anaphylactic reactions are hyperacute in 
nature, presenting within minutes of antigen exposure, 
with a rapid evolution of multisystem manifestations 
relating to mast-cell release. However, rarely anaphylactic 
reactions can develop in a more sub-acute fashion, and 
may develop up to 72 h following initial exposure—as can 
be seen with penicillin reactions [15]. Whether or not 
the mechanism is similar to biphasic reactions which one 
group suggested may be related to an extended inflamma-
tory process triggered by the initial IgE reaction remains 
unclear [16]. A possible contributor in our patient may 
have been the presence of residual gel on the vaginal 
mucous membrane which led to ongoing antigenic expo-
sure, though the actual mechanism is not known.
Gels and lubricating agents serve multiple purposes 
in the healthcare setting, typically in relation to proce-
dures that involve mucous membranes. Other common 
gel constituents that may rarely be associated with ana-
phylaxis include methyl celluloses (which the gel used 
for this procedure also contained) and chlorhexidine [12, 
13]. Periprocedural anaphylaxis in the health-care setting 
can also be related to the use of latex-containing gloves 
or barrier devices, such as condoms that are used for 
transvaginal ultrasounds.
As there are limited reports of PEG-associated ana-
phylaxis, the degree to which the administration route or 
molecular weight influences the nature of the reaction is 
not clear [17]. In addition to a suggestive history, an IgE-
related mechanism is supported by positive skin prick 
testing to multiple PEG-containing products of varying 
molecular weights, positive basophil histamine release 
Fig. 1 Skin prick testing result for ultrasound gel vs positive hista-
mine control
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assays, and suppression of histamine release through the 
utilization of omalizumab and both mono- and dimeric 
fractions of PEGs [8, 18].
Given the presumed rarity of PEG hypersensitivity, 
and its presence in many different products and formu-
lations with a myriad of exposure routes, it is unclear 
who might be at risk. Further complicating matters is 
that the development of hypersensitivity might not even 
be to PEG itself, but to substances that contain com-
pounds which have moieties that resemble PEG [19]. 
Despite the widespread use of PEG, the prevalence of 
reactions attributable to PEG exposure would seem to 
be low. However, PEG-induced reactions may be more 
common than we think—and might explain cases of idi-
opathic anaphylaxis.
For those in whom a PEG-related allergy is suspected, 
one group suggested an oral challenge to identify a 
threshold exposure level that might enable specific guid-
ance regarding avoidance strategies [17]. However, oral 
provocation in that patient resulted in a multisystem 
reaction that necessitated administration of antihista-
mine and intravenous steroid. Despite poor alimentary 
absorption of high molecular weight PEG solutions, 
low levels can be detected in the urine (implying sys-
temic absorption) and appear to be adequate for ana-
phylaxis [4]. Moreover, given the rising prevalence of 
PEGylated drugs to help prolong drug half-life, prescrib-
ers and patients should be made aware that anaphylaxis 
to mucosally-exposed PEG may also increase the risk of 
patients reacting to PEGylated drugs, as predicted by 
skin prick testing [9]. Patients with anaphylaxis to PEG 
can thus also react to PEGylated drugs. Overall, skin 
prick testing is the best diagnostic modality from a safety 
perspective, though basophil histamine release assays can 
also be used. As aforementioned, despite the purported 
mechanism being IgE-mediated, at present there is no 
assay of which we are aware for the measurement of anti-
PEG IgE antibodies.
As with all suspected or confirmed instances of IgE-
mediated hypersensitivity, management should be strict 
avoidance of the culprit antigens. However, the lack of 
consistent labelling and identification of PEG as a chemi-
cal constituent in many products makes this a challenge 
[8]. Thus, obvious avoidance measures should be recom-
mended and include laxatives and colonoscopic prepara-
tions, as well as substances used for procedures involving 
mucous membranes, but patients should be advised to 
read labels. Of note, though PEG is the most widely used 
agent for colonoscopic preparation, other options are 
available [6]. Nevertheless, avoidance strategies are laden 
with the potential for error, and as a result, patients with 
PEG allergy should carry an epinephrine autoinjector as 
a safety net.
Conclusion
This case demonstrates that mucosal exposure to PEG 
found in lubricating gel can trigger anaphylaxis and raises 
the possibility that PEG may be an unrecognized aller-
gen in the healthcare setting. All cases of anaphylaxis 
need a thorough investigation to identify exact causation. 
It cannot be assumed that all reactions are caused by 
more common allergens such as natural rubber latex, or 
alternative antigens such as methyl celluloses and chlo-
rhexidine. Thus, healthcare sites where providers per-
form procedures such as internal ultrasounds or physical 
examinations should be aware of this rare, but poten-
tially fatal complication of performing what are generally 
thought of as routine medical interventions with little 
risk aided by PEG-containing lubricants. Further study 
is needed to evaluate the prevalence of PEG hypersen-
sitivity and to clarify who might have a heightened risk. 
Providers should be educated on the possibility of PEG 
hypersensitivity and be able to recognize the early signs 
of anaphylaxis in order to enable appropriate medical 
care, consultation, or transfer to an acute medical facility.
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